48 results
Page 2 of 3
POS AM
mim6rgbqqvh6zfzrie0n
30 Mar 22
Prospectus update (post-effective amendment)
7:32am
10-K
k7nrdugtvzwzzh5r
29 Mar 22
Annual report
5:29pm
8-K
EX-99.1
xfb 1o7f7s1olth
29 Mar 22
Pardes Biosciences Reports Full Year 2021 Financial Results and Provides Business Update
4:05pm
424B3
qgyc8usbhwl mm9x
2 Mar 22
Prospectus supplement
4:23pm
8-K
EX-99.1
atbs6i6
2 Mar 22
Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board
4:16pm
8-K
EX-99.2
n9vqgft7
14 Feb 22
Regulation FD Disclosure
7:26am
424B3
zh453sl hzifbngdzwf
1 Feb 22
Prospectus supplement
5:03pm
8-K
EX-99.1
aooldzqfx43
7 Jan 22
Regulation FD Disclosure
7:00am
8-K
q9w3sanichur co
30 Dec 21
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
tdoc8dr qndea299rm5b
30 Dec 21
Entry into a Material Definitive Agreement
4:55pm
424B3
tqcjsdyz
1 Dec 21
Prospectus supplement
12:06pm
425
EX-99.1
76ll ir2e
18 Nov 21
Business combination disclosure
9:14am
8-K
EX-99.1
c4i4cet
18 Nov 21
Regulation FD Disclosure
9:02am
S-4/A
iw4 cdiieau
14 Sep 21
Registration of securities issued in business combination transactions (amended)
6:45am
S-4
prxk3 aql3ks605d5
4 Aug 21
Registration of securities issued in business combination transactions
3:02pm